Abstract
Purpose
Aging increases oxidative stress, which can have delirious effects on smooth and striated muscle resulting in bladder dysfunction. Consequently, in women aged over 60 years, urinary incontinence (UI) is a prevalent health problem. Despite the prevalence and consequences, UI continues to be undertreated simply because there are few therapeutic options.
Methods
Here we investigated whether 8-aminoguanine (8-AG), a purine nucleoside phosphorylase (PNPase inhibitor), would restore urethra and external sphincter (EUS) muscle morphology in the aged rat. Aged (> 25 months) female Fischer 344 rats were randomized to oral treatment with 8-AG (6 weeks) or placebo, and the urethra and EUS were evaluated by electron microscopy and protein expression (western immunoblotting).
Results
Aging was associated with mitochondrial degeneration in smooth and striated muscle cells as compared to young rats. We also observed a significant increase in biomarkers such as PARP, a downstream activator of oxidative/nitrosative stress. Treatment of aged rats with 8-AG normalized all abnormalities to that of a younger state.
Conclusions
8-AG, a potent inhibitor of PNPase, reverses age-related lower urinary tract morphological and biochemical changes. Our observations support the concept that 8-AG will reverse age-induced lower urinary tract disorders such as UI. These initial findings could have therapeutic implications for the prevention and treatment of age-related UI.
Similar content being viewed by others
References
Pfisterer MH, Griffiths DJ, Schaefer W, Resnick NM (2006) The effect of age on lower urinary tract function: a study in women. JAGS 54:405–412
Dubeau CE (2006) The aging lower urinary tract. J Urol 175:S11-15
Gibson W, Wagg A (2017) Incontinence in the elderly, ‘normal’ ageing, or unaddressed pathology? Nat Rev Urol 14:440–447
Delancey JOL, Ashton-miller JA (2004) Pathophysiology of adult urinary incontinence. Gastroenterology 1126:S23-32
Wagg A, Chen L, Krischner-Hermans T, Kuchel G, Johnson T, Ostaszeiwica J (2013) Incontinence in the frail elderly, in incontinence. Abrams P, Cardozo L, Khoury S, Wein A (Eds). International continence society: Bristol, UK. p. 1001–101.
Andersson K (2018) Oxidative stress and its possible relation to lower urinary tract functional pathology. BJU Int 121:527–533
Del Maestro RF (1980) An approach to free radicals in medicine and biology. Acta Physiol Scand Suppl 492:153–168
Abrigo J, Elorza A, Riedel CA, Vilos C, Simon F, Cabello-Verrugio C (2018) Role of oxidative stress as key regulator of muscle wasting during cachexia. Oxid Med Cell Longev. https://doi.org/10.1155/2018/2063179
Jackson EK, Gillespie DG, Mi Z (2016) 8-Aminoguanosine and 8-aminoguanine exert diuretic, naturetic, glucosuric, and antihypertensive activity. JPET 359:420–435
Sircar J, Suto J, Scott M, Dong M, Gilbertsen R (1986) Inhibitors of human purine nucleoside phosphorylase. J Med Chem 29:1804–1806
Luo X, Kraus WL (2012) On PAR with PARP: cellular stress signaling through poly (ADP-ribose) and PARP-1. Genes Dev 26:417–432
Rao P, Walsh T, Makowka L, Rubin R, Weber T, Synder J, Starzl T (1990) Purine nucleoside phosphorylase: a mew marker for free oxygen radical injury to the endothelial cell. Hepatology 11:193–198
Granger D, Kvietys PR (2015) Reperfusion injury and reactive oxygen species: the evolution of a concept. Redox Biol 6:524–551
Abrigo J, Rivera J, Avavena J, Cabrera D, Simon F, Cabello-Verrugio C (2016) High fat diet induced skeletal muscle wasting is decreased by mesenchymal stem cells: implications on oxidative stress, ubiquitin proteasome pathway activation and myonuclear apoptosis. Oxid Med Cell Longev. https://doi.org/10.1155/2016/9047821
Gouspillou G, Bourdel-Marchasson I, Rouland R, Calmettes G, Biran M, Deschodt-Arsac V, Miraux S, Thiaudiere E, Pasdois P, Diolex P (2014) Mitochondrial energetics is impaired in vivo in aged skeletal muscle. Aging Cell 13:39–48
von Haehling S, Anker SD (2014) Prevalence, incidence and clinical impact of cachexia: facts and numbers-updated. J Cachexia Sarcopenia Muscle 5:261–263
Lin AT, Hsu TH, Yang C, Chang LS (2000) Effects of aging on mitochondrial enzyme activity of rat urinary bladder. Urol Int 65:144–147
Teunissen D, van Weel C, Lagro-Janssen T (2005) UI in older people living in the community: examining help-seeking behavior. Br J Gen Pract 55:776–782
Aoki Y, Brown HW, Brubaker L, Cornu JN, Daly JO, Cartwright R (2018) Urinary incontinence in women. Nat Rev Dis Primers. https://doi.org/10.1038/nrdp.2017.42
Luber KM (2004) The definition, prevalence and risk factors for stress urinary incontinence. Rev Urol 6:S3-9
Irwin GM (2019) Urinary incontinence. Prim Care Clin Off Pract 46:233–242
Nomiya M, Andersson KE, Yamaguchi O (2015) Chronic bladder ischemia and oxidative stress: new pharmacotherapeutic targets for lower urinary tract symptoms. Int J Urol 22:40–46
Wu JM, Kawasaki A, Hundley AF, Dieter AA, Myers ER, Sung VW (2011) Predicting the number of women who will undergo incontinence and prolapse surgery, 2010 to 2050. Am J Obstet Gynecol 205:230.e1-230.e5
Newman DK, Wein AJ (2009) Managing and treating urinary incontinence. Health Professions Press, Ann Arbor
Andersson KE, Appell R, Cardozo LD, Chapple C, Drutz HP, Finkbeiner AE, Haab F, Navarrete RV (1999) The pharmacological treatment of urinary incontinence. BJU Int 84:923–947
Shah D, Badlani G (2002) Treatment of overactive bladder and incontinence in the elderly. Rev Urol 4:S38-43
Gomelsky A, Dmochowski RR (2011) Treatment of mixed urinary incontinence. Central Eur J Urol 64:120–124
Moga DC, Abner EL, Wu Q, Jicha GA (2017) Bladder antimuscarinics and cognitive decline in elderly patients. Alzheimers Dement 3:139–148
Acknowledgements
The work was supported by the National Institutes of Health (R01 AG056944, R56 AG063753 and R01 DK079307).
Funding
Funding was supported by NIH (R01 AG056944, R56 AG063753 and R01 DK079307).
Author information
Authors and Affiliations
Contributions
Project development/original draft preparation: LAB and EKJ; data collection/analysis: AW-J, MG-S, DS, and SW; manuscript writing/editing: AJW, DN, and RRD.
Corresponding author
Ethics declarations
Conflict of interest
Authors M Grove-Sullivan, D Stoltz, S Watkins and D Newman have no relevant financial or non-financial interests to disclose; patent (pending) for authors L Birder, E Jackson, A Wolf-Johnston, A Wein and R Dmochowski.
Ethical approval
The IACUC approved all procedures and conform to the Guide for the Care and Use of Laboratory Animals published by the US NIH (NIH Publication No. 85-23, revised 1996).
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Birder, L.A., Wolf-Johnston, A., Wein, A.J. et al. A uro-protective agent with restorative actions on urethral and striated muscle morphology. World J Urol 39, 2685–2690 (2021). https://doi.org/10.1007/s00345-020-03492-6
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00345-020-03492-6